Replies to post #17484 on Radient Pharmaceuticals Corporation fka RXPC

[jimtash]

That's just a precaution for the upcoming trial. What's also being left out is details about this present patent filing and namely Andrea Small-Howard.

Current

Board Member at Center for Healthcare Innovation
President at International Biotechnology Solutions

Past

Board Member at Ceremax Investment Corporation
Vice President, Scientific Oversight at Radient Pharmaceuticals Corporation
Master of Business Admistration at USC Marshall School of Business

http://www.linkedin.com/in/andreasmallhowardphd



7.3

UNI hereby agrees to prosecute the two unissued patents as identified in Exhibit A hereto attached and RXPC hereby agrees that UNI shall be granted, by way of and under the protection of the March-In Rights of this Section 7, full and exclusive assignment and transfer of rights and entitlement to the two unissued patents as identified in Exhibit A hereto attached in the event RXPC is confronted with, served, and or interrupted by bankruptcy proceedings, or if any similar legal action, circumstance, or claim against RXPC were to occur that could normally disrupt RXPC’s business and or ability to deliver the Tests, or in any way attempt to terminate this License Agreement.